share_log

MusclePharm (OTCMKTS:MSLP) Stock Price Passes Below Two Hundred Day Moving Average of $0.23

MusclePharm (OTCMKTS:MSLP) Stock Price Passes Below Two Hundred Day Moving Average of $0.23

MusclePharm(场外交易代码:MSLP)股价跌破200日移动均线0.23美元
Financial News Live ·  2022/09/10 10:02

MusclePharm Co. (OTCMKTS:MSLP – Get Rating)'s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.23 and traded as low as $0.20. MusclePharm shares last traded at $0.20, with a volume of 110 shares.

在周四的交易中,MusclePharmCo.的股价跌破了200日移动均线,200日移动均线切入位为0.23美元,最低交易价格为0.20美元。MusclePharm股价最新报0.20美元,成交量为110股。

MusclePharm Stock Performance

MusclePharm股票表现

The company has a fifty day simple moving average of $0.18 and a 200-day simple moving average of $0.23.

该公司的50日简单移动均线切入位为0.18美元,200日简单移动均线切入位为0.23美元。

About MusclePharm

关于MusclePharm

(Get Rating)

(获取评级)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.

公司在美国和国际上开发、制造、营销和分销运动营养品和营养补充剂。该公司提供一系列高性能粉末、胶囊、片剂、凝胶和随时可用的零食。该公司的MusclePharm品牌产品组合包括战斗蛋白粉和战斗挤压蛋白棒;以及支链氨基酸、肌酸、谷氨酰胺、肉碱、共轭亚油酸、鱼油、多种维生素和其他产品等基本补充剂。

Featured Stories

专题报道

  • Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
  • MarketBeat: Week in Review 9/5 – 9/9
  • Prepare For A Record-Setting Quarter For Cyber Security Stocks
  • The Auto Market Is Slowly Recovering, These Stocks May Outperform
  • Is DocuSign On The Verge Of A Major Reversal?
  • Oil and Gas Stocks: A Safe Way to Invest in Renewable Energy
  • 免费获取StockNews.com关于MusclePharm的研究报告(MSLP)
  • MarketBeat:回顾一周9/5-9/9
  • 为网络安全股创纪录的季度做准备
  • 汽车市场正在缓慢复苏,这些股票可能表现优异
  • DocuSign是否即将发生重大逆转?
  • 石油和天然气股票:投资可再生能源的安全途径

Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.

接受MusclePharm日报的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯收到对MusclePharm和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发